Author - David Miller
Engaging with Launch Partners Early in Development
John Arena, interim president of global pharma services at Cencora, discusses the importance of...
STAT+: Pfizer CEO Albert Bourla inflicts injury on his company...
It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided:...
Incyte, Genesis Therapeutics to Use AI Platform to Discover...
The collaboration will utilize Genesis’ proprietary AI platform, initially focusing on targets...
Popular Flu Vaccine Educational Campaign Ending at CDC
Anonymous reports claim the decision came from new leadership at HHS.
Gilead Treatment for PBC Granted EC Conditional Marketing...
Seladelpar, which is marketed in the US as Livdelzi, was recommended for an orphan drug designation...
Fast-Tracking Development: How Life Sciences Will Drive Speed in...
Biopharmas and global agencies are now prioritizing initiatives and innovations to drive speed...
STAT+: UnitedHealth buyouts, and drug pricing spreads
This is the online version of STAT’s email newsletter Health Care Inc, delivered to your inbox...
Small Change: FDA’s Final Predetermined Change Control Plan...
By Lisa M. Baumhardt, Principal Medical Device Regulatory Expert — FDA recently released its...
Pharma Pulse 2/24/25: Enhancing Pharma Supply Chain Transparency...
The latest news for pharma industry insiders.